Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study (Q84508670)
Jump to navigation
Jump to search
scientific article published on 05 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study |
scientific article published on 05 May 2011 |
Statements
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study (English)
Wolfgang Herr
Mathias Hänel
Gautham Borthakur
Arthur Frankel
Heinz-August Horst
Sonja Martin
Jeannine Kassis
Pierre Desjardins
Karen Seiter
Walter Fiedler
Richard Noppeney
Aristoteles Giagounidis
Christine Jacob
Jacques Jolivet
Martin S Tallman